KLAC KLA CORP More: the full row for KLA CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 15,848 shares; 2025Q3: 21,883 shares; 2025Q4: 21,883 shares; 2026Q1: 19,883 shares; 2026Q2: 178,471 shares; 2026Q3: 166,938 shares 166,938 $32.5M 18.8% -11,533 Timeline BMY BRISTOL-MYERS SQUIBB CO More: the full row for BRISTOL-MYERS SQUIBB CO Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 685,182 shares; 2025Q1: 685,192 shares; 2025Q2: 323,358 shares; 2025Q3: 316,842 shares; 2025Q4: 302,842 shares; 2026Q1: 306,268 shares; 2026Q2: 297,243 shares; 2026Q3: 224,245 shares 224,245 $14M 8.08% -72,998 Timeline LRCX LAM RESEARCH CORP More: the full row for LAM RESEARCH CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 40,329 shares; 2026Q1: 36,000 shares; 2026Q2: 35,000 shares; 2026Q3: 30,000 shares 30,000 $9.86M 5.69% -5,000 Timeline BIODESIX INC BIODESIX INC More: the full row for BIODESIX INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 5,736,113 shares; 2025Q1: 5,736,113 shares; 2025Q2: 5,736,113 shares; 2025Q3: 286,804 shares; 2025Q4: 286,804 shares; 2026Q1: 286,804 shares; 2026Q2: 286,804 shares; 2026Q3: 286,804 shares 286,804 $8.56M 4.94% 0 CORT CORCEPT THERAPEUTICS INC More: the full row for CORCEPT THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 74,000 shares; 2025Q1: 66,000 shares; 2025Q2: 67,200 shares; 2025Q3: 67,200 shares; 2025Q4: 67,200 shares; 2026Q1: 47,200 shares; 2026Q2: 57,200 shares; 2026Q3: 55,200 shares 55,200 $6.36M 3.67% -2,000 Timeline OVV OVINTIV INC More: the full row for OVINTIV INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 52,200 shares; 2025Q1: 52,200 shares; 2025Q2: 107,500 shares; 2025Q3: 107,500 shares; 2025Q4: 107,500 shares; 2026Q1: 107,500 shares; 2026Q2: 107,500 shares; 2026Q3: 107,500 shares 107,500 $6.22M 3.59% 0 Timeline RARE ULTRAGENYX PHARMACEUTICAL IN More: the full row for ULTRAGENYX PHARMACEUTICAL IN Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 16,000 shares; 2025Q1: 16,000 shares; 2025Q2: 18,000 shares; 2025Q3: 22,000 shares; 2025Q4: 62,000 shares; 2026Q1: 62,000 shares; 2026Q2: not reported; 2026Q3: 373,671 shares 373,671 $5.62M 3.24% new Timeline SLDB SOLID BIOSCIENCES INC More: the full row for SOLID BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 128,768 shares; 2025Q2: 178,768 shares; 2025Q3: 296,955 shares; 2025Q4: 705,955 shares; 2026Q1: 625,980 shares; 2026Q2: 666,196 shares; 2026Q3: 715,955 shares 715,955 $5.18M 2.99% +49,759 Timeline PTGX PROTAGONIST THERAPEUTICS INC More: the full row for PROTAGONIST THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 48,000 shares; 2025Q1: 48,002 shares; 2025Q2: 48,000 shares; 2025Q3: 48,000 shares; 2025Q4: 55,000 shares; 2026Q1: 35,000 shares; 2026Q2: 35,018 shares; 2026Q3: 35,000 shares 35,000 $4.93M 2.85% -18 Timeline PRTA PROTHENA CORP PLC More: the full row for PROTHENA CORP PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 304,574 shares; 2025Q1: 332,974 shares; 2025Q2: 451,019 shares; 2025Q3: 549,019 shares; 2025Q4: 441,019 shares; 2026Q1: 449,019 shares; 2026Q2: 449,019 shares; 2026Q3: 449,019 shares 449,019 $3.76M 2.17% 0 Timeline HALO HALOZYME THERAPEUTICS INC More: the full row for HALOZYME THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 10,000 shares; 2025Q1: 10,000 shares; 2025Q2: 10,000 shares; 2025Q3: 10,100 shares; 2025Q4: 10,100 shares; 2026Q1: 10,100 shares; 2026Q2: 33,251 shares; 2026Q3: 33,351 shares 33,351 $3.68M 2.13% +100 Timeline STOK STOKE THERAPEUTICS INC More: the full row for STOKE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 210,000 shares; 2025Q1: 210,005 shares; 2025Q2: 210,000 shares; 2025Q3: 210,000 shares; 2025Q4: 260,000 shares; 2026Q1: 210,000 shares; 2026Q2: 178,110 shares; 2026Q3: 138,000 shares 138,000 $3.59M 2.07% -40,110 Timeline NBIX NEUROCRINE BIOSCIENCES INC More: the full row for NEUROCRINE BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 30,240 shares; 2025Q1: 30,240 shares; 2025Q2: 30,940 shares; 2025Q3: 28,690 shares; 2025Q4: 27,190 shares; 2026Q1: 27,190 shares; 2026Q2: 27,190 shares; 2026Q3: 25,190 shares 25,190 $3.57M 2.06% -2,000 Timeline ACAD ACADIA PHARMACEUTICALS INC More: the full row for ACADIA PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 338,400 shares; 2025Q1: 263,400 shares; 2025Q2: 187,800 shares; 2025Q3: 171,000 shares; 2025Q4: 171,000 shares; 2026Q1: 171,000 shares; 2026Q2: 171,000 shares; 2026Q3: 171,000 shares 171,000 $3.45M 1.99% 0 Timeline NTLA INTELLIA THERAPEUTICS INC More: the full row for INTELLIA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 60,000 shares; 2025Q3: 60,000 shares; 2025Q4: 315,400 shares; 2026Q1: 445,400 shares; 2026Q2: 385,900 shares; 2026Q3: 281,365 shares 281,365 $3.39M 1.96% -104,535 Timeline NKTR NEKTAR THERAPEUTICS More: the full row for NEKTAR THERAPEUTICS Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 4,021 shares; 2025Q4: 31,000 shares; 2026Q1: 31,000 shares; 2026Q2: 81,000 shares; 2026Q3: 46,000 shares 46,000 $2.79M 1.61% -35,000 Timeline VIR VIR BIOTECHNOLOGY INC More: the full row for VIR BIOTECHNOLOGY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 220,000 shares; 2026Q3: 226,992 shares 226,992 $2.54M 1.47% +6,992 Timeline ZBIO ZENAS BIOPHARMA INC More: the full row for ZENAS BIOPHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 16,500 shares; 2025Q1: 16,500 shares; 2025Q2: 16,500 shares; 2025Q3: 16,500 shares; 2025Q4: not reported; 2026Q1: 70,000 shares; 2026Q2: 93,601 shares; 2026Q3: 93,380 shares 93,380 $2.52M 1.45% -221 Timeline CONTINEUM THERAPEUTICS INC CONTINEUM THERAPEUTICS INC More: the full row for CONTINEUM THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 3,500 shares 3,500 $2.27M 1.31% new ABVX ABIVAX SA More: the full row for ABIVAX SA Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 17,000 shares; 2026Q3: 21,000 shares 21,000 $2.08M 1.2% +4,000 Timeline BIIB BIOGEN INC More: the full row for BIOGEN INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 5,000 shares; 2026Q2: 9,000 shares; 2026Q3: 9,000 shares 9,000 $2.03M 1.17% 0 Timeline ALKS ALKERMES PLC More: the full row for ALKERMES PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 50,000 shares; 2025Q1: 50,000 shares; 2025Q2: 50,000 shares; 2025Q3: 50,000 shares; 2025Q4: 50,000 shares; 2026Q1: 50,000 shares; 2026Q2: 50,000 shares; 2026Q3: 50,000 shares 50,000 $2.03M 1.17% 0 Timeline DFTX DEFINIUM THERAPEUTICS INC More: the full row for DEFINIUM THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 20,000 shares; 2026Q3: 52,000 shares 52,000 $1.98M 1.14% +32,000 Timeline CYTK CYTOKINETICS INC More: the full row for CYTOKINETICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 10,000 shares; 2025Q1: 10,000 shares; 2025Q2: 10,000 shares; 2025Q3: 30,000 shares; 2025Q4: 30,000 shares; 2026Q1: 30,000 shares; 2026Q2: 30,000 shares; 2026Q3: 30,000 shares 30,000 $1.98M 1.14% 0 Timeline CLDX CELLDEX THERAPEUTICS INC NEW More: the full row for CELLDEX THERAPEUTICS INC NEW Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 70,095 shares; 2026Q2: 69,900 shares; 2026Q3: 57,200 shares 57,200 $1.85M 1.07% -12,700 Timeline EQT EQT CORP More: the full row for EQT CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 34,619 shares; 2025Q1: 34,619 shares; 2025Q2: 34,619 shares; 2025Q3: 34,619 shares; 2025Q4: 34,619 shares; 2026Q1: 34,619 shares; 2026Q2: 34,619 shares; 2026Q3: 34,619 shares 34,619 $1.68M 0.97% 0 Timeline CMPX COMPASS THERAPEUTICS INC More: the full row for COMPASS THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 24,000 shares; 2025Q2: not reported; 2025Q3: 872,938 shares; 2025Q4: 1,592,938 shares; 2026Q1: 1,465,867 shares; 2026Q2: 1,675,000 shares; 2026Q3: 1,575,000 shares 1,575,000 $1.64M 0.95% -100,000 Timeline XENE XENON PHARMACEUTICALS INC More: the full row for XENON PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 10,000 shares; 2025Q1: 21,000 shares; 2025Q2: 21,000 shares; 2025Q3: 21,000 shares; 2025Q4: 21,000 shares; 2026Q1: 21,000 shares; 2026Q2: 21,032 shares; 2026Q3: 42,995 shares 42,995 $1.6M 0.92% +21,963 Timeline RLMD RELMADA THERAPEUTICS INC More: the full row for RELMADA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 409,387 shares; 2026Q2: 408,100 shares; 2026Q3: 408,100 shares 408,100 $1.54M 0.89% 0 Timeline TVTX TRAVERE THERAPEUTICS INC More: the full row for TRAVERE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 148,000 shares; 2025Q1: 138,000 shares; 2025Q2: 103,000 shares; 2025Q3: 43,060 shares; 2025Q4: 43,000 shares; 2026Q1: 29,200 shares; 2026Q2: 29,000 shares; 2026Q3: 25,000 shares 25,000 $1.47M 0.85% -4,000 Timeline ADAG ADAGENE INC More: the full row for ADAGENE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 240,000 shares; 2026Q3: 430,000 shares 430,000 $1.38M 0.79% +190,000 Timeline UTHR UNITED THERAPEUTICS CORP DEL More: the full row for UNITED THERAPEUTICS CORP DEL Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 10,000 shares; 2025Q1: 7,500 shares; 2025Q2: 4,250 shares; 2025Q3: 3,000 shares; 2025Q4: 3,000 shares; 2026Q1: 4,500 shares; 2026Q2: 4,506 shares; 2026Q3: 2,500 shares 2,500 $1.35M 0.78% -2,006 Timeline FCX FREEPORT MCMORAN INC More: the full row for FREEPORT MCMORAN INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 18,033 shares; 2025Q3: 18,044 shares; 2025Q4: 18,046 shares; 2026Q1: 18,040 shares; 2026Q2: 18,035 shares; 2026Q3: 18,027 shares 18,027 $1.26M 0.73% -8 Timeline IRLA QUINCE THERAPEUTICS INC More: the full row for QUINCE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 40,601 shares 40,601 $1.26M 0.73% new Timeline VALN VALNEVA SE More: the full row for VALNEVA SE Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 201,390 shares 201,390 $1.25M 0.72% new Timeline BBIO BRIDGEBIO PHARMA INC More: the full row for BRIDGEBIO PHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 5,000 shares; 2025Q3: 8,688 shares; 2025Q4: 8,688 shares; 2026Q1: 8,688 shares; 2026Q2: 8,741 shares; 2026Q3: 18,741 shares 18,741 $1.23M 0.71% +10,000 Timeline IMNM IMMUNOME INC More: the full row for IMMUNOME INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 60,000 shares; 2025Q3: 105,000 shares; 2025Q4: 130,000 shares; 2026Q1: 50,000 shares; 2026Q2: 50,000 shares; 2026Q3: 55,600 shares 55,600 $1.2M 0.69% +5,600 Timeline AXSM AXSOME THERAPEUTICS INC. More: the full row for AXSOME THERAPEUTICS INC. Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,000 shares; 2025Q1: 6,000 shares; 2025Q2: 6,000 shares; 2025Q3: 6,000 shares; 2025Q4: 6,061 shares; 2026Q1: 6,000 shares; 2026Q2: 6,000 shares; 2026Q3: 6,000 shares 6,000 $1.11M 0.64% 0 Timeline ANNEXON INC ANNEXON INC More: the full row for ANNEXON INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 4,370 shares 4,370 $1.05M 0.61% new JATT JATT II ACQUISITION CORP More: the full row for JATT II ACQUISITION CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 90,455 shares 90,455 $1.02M 0.59% new Timeline FHTX FOGHORN THERAPEUTICS INC More: the full row for FOGHORN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 310,930 shares; 2025Q1: 310,930 shares; 2025Q2: 310,930 shares; 2025Q3: 281,730 shares; 2025Q4: 281,730 shares; 2026Q1: 281,730 shares; 2026Q2: 281,937 shares; 2026Q3: 282,307 shares 282,307 $1.01M 0.58% +370 Timeline PHVS PHARVARIS N V More: the full row for PHARVARIS N V Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 14,847 shares; 2025Q4: 29,847 shares; 2026Q1: 29,847 shares; 2026Q2: 29,847 shares; 2026Q3: 29,847 shares 29,847 $947K 0.55% 0 Timeline QUIDELORTHO CORP QUIDELORTHO CORP More: the full row for QUIDELORTHO CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 67,619 shares; 2025Q1: 67,619 shares; 2025Q2: 72,548 shares; 2025Q3: 72,548 shares; 2025Q4: 72,548 shares; 2026Q1: 82,548 shares; 2026Q2: 89,377 shares; 2026Q3: 89,377 shares 89,377 $942K 0.54% 0 BLSM BLOSSOMHILL THERAPEUTICS INC More: the full row for BLOSSOMHILL THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 50,000 shares 50,000 $932K 0.54% new Timeline DISC MEDICINE INC DISC MEDICINE INC More: the full row for DISC MEDICINE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 450 shares 450 $842K 0.49% new CSTL CASTLE BIOSCIENCES INC More: the full row for CASTLE BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 78,000 shares; 2025Q1: 88,404 shares; 2025Q2: 110,600 shares; 2025Q3: 110,600 shares; 2025Q4: 80,600 shares; 2026Q1: 12,900 shares; 2026Q2: 12,984 shares; 2026Q3: 22,935 shares 22,935 $815K 0.47% +9,951 Timeline DRUG BRIGHT MINDS BIOSCIENCES INC More: the full row for BRIGHT MINDS BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 15,400 shares 15,400 $767K 0.44% new Timeline HROW HARROW INC More: the full row for HARROW INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 72,910 shares; 2025Q1: 72,910 shares; 2025Q2: 60,000 shares; 2025Q3: 40,000 shares; 2025Q4: 34,000 shares; 2026Q1: 24,000 shares; 2026Q2: 24,000 shares; 2026Q3: 24,000 shares 24,000 $739K 0.43% 0 Timeline BCYC BICYCLE THERAPEUTICS PLC More: the full row for BICYCLE THERAPEUTICS PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 154,000 shares; 2025Q4: 462,700 shares; 2026Q1: 463,599 shares; 2026Q2: 313,616 shares; 2026Q3: 176,432 shares 176,432 $649K 0.38% -137,184 Timeline VYGR VOYAGER THERAPEUTICS INC More: the full row for VOYAGER THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 134,918 shares; 2025Q4: 74,918 shares; 2026Q1: 74,918 shares; 2026Q2: 75,147 shares; 2026Q3: 224,918 shares 224,918 $603K 0.35% +149,771 Timeline SLGL SOL-GEL TECHNOLOGIES LTD More: the full row for SOL-GEL TECHNOLOGIES LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 7,600 shares 7,600 $565K 0.33% new Timeline OLMA OLEMA PHARMACEUTICALS INC More: the full row for OLEMA PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 134,000 shares; 2025Q3: 174,000 shares; 2025Q4: 269,000 shares; 2026Q1: 219,000 shares; 2026Q2: 199,000 shares; 2026Q3: 59,000 shares 59,000 $510K 0.29% -140,000 Timeline CRMD CORMEDIX INC More: the full row for CORMEDIX INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 65,874 shares 65,874 $507K 0.29% new Timeline CAMP CAMP4 THERAPEUTICS CORP More: the full row for CAMP4 THERAPEUTICS CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 120,000 shares; 2026Q3: 120,000 shares 120,000 $485K 0.28% 0 Timeline ABEO ABEONA THERAPEUTICS INC More: the full row for ABEONA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 90,700 shares 90,700 $476K 0.28% new Timeline ALT ALTIMMUNE INC More: the full row for ALTIMMUNE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 152,681 shares; 2026Q3: 160,964 shares 160,964 $460K 0.27% +8,283 Timeline VOR VOR BIOPHARMA INC More: the full row for VOR BIOPHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 24,000 shares 24,000 $458K 0.26% new Timeline MLTX MOONLAKE IMMUNOTHERAPEUTICS More: the full row for MOONLAKE IMMUNOTHERAPEUTICS Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,000 shares; 2025Q1: 8,000 shares; 2025Q2: 8,000 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 36,220 shares 36,220 $424K 0.24% new Timeline AEMD AETHLON MED INC More: the full row for AETHLON MED INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 62,837 shares 62,837 $410K 0.24% new Timeline LUNG PULMONX CORP More: the full row for PULMONX CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 51,000 shares; 2025Q1: 51,000 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 250,573 shares; 2026Q1: 250,221 shares; 2026Q2: 200,543 shares; 2026Q3: 200,000 shares 200,000 $382K 0.22% -543 Timeline PACB PACIFIC BIOSCIENCES CALIF IN More: the full row for PACIFIC BIOSCIENCES CALIF IN Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 400,000 shares; 2025Q3: 500,000 shares; 2025Q4: 500,000 shares; 2026Q1: 1,500,000 shares; 2026Q2: 1,350,000 shares; 2026Q3: 160,000 shares 160,000 $379K 0.22% -1,190,000 Timeline TRIN TRINITY CAP INC More: the full row for TRINITY CAP INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 20,000 shares; 2026Q1: 20,000 shares; 2026Q2: 20,000 shares; 2026Q3: 20,000 shares 20,000 $351K 0.2% 0 Timeline SLN SILENCE THERAPEUTICS PLC More: the full row for SILENCE THERAPEUTICS PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 71,218 shares; 2026Q3: 30,000 shares 30,000 $328K 0.19% -41,218 Timeline CGEM CULLINAN THERAPEUTICS INC More: the full row for CULLINAN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 20,000 shares; 2025Q1: 20,000 shares; 2025Q2: 20,000 shares; 2025Q3: 20,000 shares; 2025Q4: 20,000 shares; 2026Q1: 20,000 shares; 2026Q2: 20,000 shares; 2026Q3: 20,000 shares 20,000 $307K 0.18% 0 Timeline KBDC KAYNE ANDERSON BDC INC More: the full row for KAYNE ANDERSON BDC INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 20,000 shares; 2026Q1: 20,000 shares; 2026Q2: 20,000 shares; 2026Q3: 20,000 shares 20,000 $251K 0.15% 0 Timeline RZLT REZOLUTE INC More: the full row for REZOLUTE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 60,296 shares 60,296 $250K 0.14% new Timeline TRDA ENTRADA THERAPEUTICS INC More: the full row for ENTRADA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 36,849 shares 36,849 $234K 0.14% new Timeline IMUX IMMUNIC INC More: the full row for IMMUNIC INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 21,917 shares 21,917 $204K 0.12% new Timeline CRDL CARDIOL THERAPEUTICS INC More: the full row for CARDIOL THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 100,000 shares 100,000 $166K 0.1% new Timeline OCUL OCULAR THERAPEUTIX INC More: the full row for OCULAR THERAPEUTIX INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 320,000 shares; 2026Q2: 20,655 shares; 2026Q3: 20,450 shares 20,450 $157K 0.09% -205 Timeline KAZIA THERAPEUTICS LTD KAZIA THERAPEUTICS LTD More: the full row for KAZIA THERAPEUTICS LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 16,000 shares 16,000 $154K 0.09% new KYNB KYNTRA BIO INC More: the full row for KYNTRA BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 22,566 shares; 2026Q2: 22,566 shares; 2026Q3: 22,566 shares 22,566 $150K 0.09% 0 Timeline ELUT ELUTIA INC More: the full row for ELUTIA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,225,489 shares; 2025Q1: 1,187,735 shares; 2025Q2: 1,159,059 shares; 2025Q3: 711,175 shares; 2025Q4: 263,018 shares; 2026Q1: 165,094 shares; 2026Q2: 165,094 shares; 2026Q3: 165,094 shares 165,094 $130K 0.08% 0 Timeline BMEA BIOMEA FUSION INC More: the full row for BIOMEA FUSION INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 93,500 shares 93,500 $124K 0.07% new Timeline GUTS FRACTYL HEALTH INC More: the full row for FRACTYL HEALTH INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 165,478 shares 165,478 $90.1K 0.05% new Timeline IVVD INVIVYD INC More: the full row for INVIVYD INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 342,275 shares; 2026Q3: 75,975 shares 75,975 $66.1K 0.04% -266,300 Timeline LPCN LIPOCINE INC NEW More: the full row for LIPOCINE INC NEW Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 111,786 shares; 2026Q2: 16,712 shares; 2026Q3: 16,712 shares 16,712 $36.8K 0.02% 0 Timeline DCGO DOCGO INC More: the full row for DOCGO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 764,062 shares; 2025Q1: 864,062 shares; 2025Q2: 764,062 shares; 2025Q3: 764,062 shares; 2025Q4: 49,908 shares; 2026Q1: 39,573 shares; 2026Q2: 39,062 shares; 2026Q3: 39,062 shares 39,062 $15.6K 0.01% 0 Timeline CELG-R BRISTOL-MYERS SQUIBB CO More: the full row for BRISTOL-MYERS SQUIBB CO Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 98,527 shares 98,527 $12.3K 0.01% new Timeline